Tags BioLargoTech
Tag: BioLargoTech
BioLargo's Q3 2025 report shows tech traction in PFAS, Clyra™, and Cellinity™ — but monetization remains elusive post-Pooph® fallout.
BioLargo's Q2 exposes value-chain gaps—regulatory lags, partner dependency, and no clear path from validation to revenue.
BioLargo’s growth hinges on its AEC, Clyra™, and Pooph® innovations, but delays and cash burn turn Q2–Q3 into a critical test for its long-term ambitions.
BioLargo CEO Dennis P. Calvert appointed to the U.S. Environmental Technologies Trade Advisory Committee as company celebrates 80% revenue growth in 2024.
BioLargo, Inc. starts its Lake Stockholm PFAS removal pilot this month with its efficient AEC technology, reducing hazardous waste by over 99% compared to GAC.
Discover the latest on BioLargo's small-scale sodium-sulfur battery manufacturing facility in Oak Ridge, Tennessee, paving the way for greener energy storage.
Explore how the Biden Administration's push for PFAS regulation in drinking water sets the stage for BioLargo's innovative solutions to shine.
BioLargo’s Gains & EPA’s PFAS Roadmap: A Deep Dive into Impacts
Explore BioLargo's Q2 2023 performance, quarter-over-quarter challenges, and future growth strategies in this insightful analysis.
Explore BioLargo's Q2 2023 performance, quarter-over-quarter challenges, and future growth strategies in this insightful analysis.
